🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Eligible patients will receive subcutaneous vaccinations of the hTERT/survi...
Status
Completed
Location
Abramson Cancer Center, University of Pennsylvania
Start Date
2012-06
Trial ID
NCT01660529
Treatments Being Tested
Part I: 12 subjects will receive an open-label 500 µl subcutaneous injecti...
Status
Completed
Location
University Hospital Tuebingen
Start Date
2020-11-27
Trial ID
NCT04546841
Treatments Being Tested
VIDO has developed a vaccine called COVAC-2. The study vaccine contains a ...
Status
Completed
Location
Canadian Center for Vaccinology, Dalhousie University
Start Date
2021-02-10
Trial ID
NCT04702178
Treatments Being Tested
VIDO has developed a vaccine called COVAC-1. The study vaccine contains a ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-06
Trial ID
NCT05155982
Treatments Being Tested
VIDO has developed a vaccine called COVAC-1. The COVAC-1 study vaccine con...
Status
Completed
Location
Diex Recherche Joliette Inc.
Start Date
2023-01-31
Trial ID
NCT05693272
Treatments Being Tested
The aim of this study is to evaluate the efficiency along with safety and t...
Status
Completed
Location
University Hospital Tuebingen
Start Date
2020-12-23
Trial ID
NCT04688385
Treatments Being Tested
The aim of this Phase I study is to evaluate the immunogenicity along with ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-05-02
Trial ID
NCT06252584
Treatments Being Tested
VIDO has developed a vaccine called COVAC-2. The COVAC-2 study vaccine con...
Status
Completed
Location
Manna Research (Burlington North)
Start Date
2022-07-22
Trial ID
NCT05226702
Treatments Being Tested
The aim of this project is to provide personalized multi-peptide vaccinatio...
Status
Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT05014607
Treatments Being Tested
The indication of this study is To evaluate the safety and immunogenicity o...
Status
Completed
Location
University Hospital Tuebingen
Start Date
2021-06-30
Trial ID
NCT04954469
Treatments Being Tested